Laboratory of Microbiology, Wageningen University & Research, Wageningen, The Netherlands.
Laboratory of Biophysics, Wageningen University & Research, Wageningen, The Netherlands.
Nucleic Acids Res. 2024 May 22;52(9):5241-5256. doi: 10.1093/nar/gkae283.
CRISPR-Cas systems have widely been adopted as genome editing tools, with two frequently employed Cas nucleases being SpyCas9 and LbCas12a. Although both nucleases use RNA guides to find and cleave target DNA sites, the two enzymes differ in terms of protospacer-adjacent motif (PAM) requirements, guide architecture and cleavage mechanism. In the last years, rational engineering led to the creation of PAM-relaxed variants SpRYCas9 and impLbCas12a to broaden the targetable DNA space. By employing their catalytically inactive variants (dCas9/dCas12a), we quantified how the protein-specific characteristics impact the target search process. To allow quantification, we fused these nucleases to the photoactivatable fluorescent protein PAmCherry2.1 and performed single-particle tracking in cells of Escherichia coli. From our tracking analysis, we derived kinetic parameters for each nuclease with a non-targeting RNA guide, strongly suggesting that interrogation of DNA by LbdCas12a variants proceeds faster than that of SpydCas9. In the presence of a targeting RNA guide, both simulations and imaging of cells confirmed that LbdCas12a variants are faster and more efficient in finding a specific target site. Our work demonstrates the trade-off of relaxing PAM requirements in SpydCas9 and LbdCas12a using a powerful framework, which can be applied to other nucleases to quantify their DNA target search.
CRISPR-Cas 系统已广泛被用作基因组编辑工具,其中两种常用的 Cas 核酸酶是 SpyCas9 和 LbCas12a。虽然这两种核酸酶都使用 RNA 向导来寻找和切割靶 DNA 位点,但这两种酶在原间隔邻近基序 (PAM) 要求、向导结构和切割机制方面存在差异。在过去的几年中,理性工程导致了 PAM 松弛变体 SpRYCas9 和 impLbCas12a 的创建,以扩大可靶向的 DNA 空间。通过使用它们的无催化活性变体 (dCas9/dCas12a),我们量化了蛋白质特异性特征如何影响靶搜索过程。为了进行量化,我们将这些核酸酶与光激活荧光蛋白 PAmCherry2.1 融合,并在大肠杆菌细胞中进行了单颗粒追踪。从我们的追踪分析中,我们为每个带有非靶向 RNA 向导的核酸酶推导出了动力学参数,这强烈表明 LbdCas12a 变体对 DNA 的探测速度快于 SpydCas9。在存在靶向 RNA 向导的情况下,模拟和细胞成像都证实了 LbdCas12a 变体在寻找特定靶位点时更快、更有效。我们的工作展示了在 SpyCas9 和 LbdCas12a 中放松 PAM 要求的权衡,使用了一个强大的框架,可以将其应用于其他核酸酶来量化它们的 DNA 靶搜索。